cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor

Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D

(2013) A.S.R. Sierksma et al.   NEUROPHARMACOLOGY

Downregulation of Brain Phosphodiesterase Type IV Measured with 11C-(R)-Rolipram Positron Emission Tomography in Major Depressive Disorder

(2012) Masahiro Fujita et al.   BIOLOGICAL PSYCHIATRY

DISC1 as a therapeutic target for mental illnesses

(2012) Takatoshi Hikida et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Phosphodiesterase-4D Knock-Out and RNA Interference-Mediated Knock-Down Enhance Memory and Increase Hippocampal Neurogenesis via Increased cAMP Signaling

(2011) Y.-F. Li et al.   JOURNAL OF NEUROSCIENCE

Brain volume abnormalities in major depressive disorder: A meta-analysis of magnetic resonance imaging studies

(2009) P. Cédric M.P. Koolschijn et al.   HUMAN BRAIN MAPPING

PET Measurement of the In Vivo Affinity of 11C-(R)-Rolipram and the Density of Its Target, Phosphodiesterase-4, in the Brains of Conscious and Anesthetized Rats

(2009) T. Itoh et al.   JOURNAL OF NUCLEAR MEDICINE

Effects of cAMP-dependent protein kinase activator and inhibitor on in vivo rolipram binding to phosphodiesterase 4 in conscious rats

(2009) Tetsuji Itoh et al.   SYNAPSE

Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population

(2008) Shusuke Numata et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS